Suppr超能文献

凯芙拉纳米纤维/氧化石墨烯复合珠粒的构建用作安全、自抗凝和高效血液灌流吸附剂。

Construction of Kevlar nanofiber/graphene oxide composite beads as safe, self-anticoagulant, and highly efficient hemoperfusion adsorbents.

机构信息

College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu 610065, China.

Laboratory of Ultrasound Imaging Drug, Department of Ultrasound, West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

J Mater Chem B. 2020 Mar 4;8(9):1960-1970. doi: 10.1039/c9tb02789k.

Abstract

Recently emerged hemoperfusion absorbents, e.g. ion-exchange resin, activated carbon, and other porous materials, provide numerous novel possibilities to cure chronic liver failure (CLF) and renal failure (CRF). However, the limited adsorption performance and unsatisfactory blood compatibility significantly impede the development of the absorbents. Hence, designing safe and self-anticoagulant hemoperfusion absorbents with robust toxin clearance remains a considerable challenge. Here, brand new Kevlar-based composite gel beads for hemoperfusion are prepared by interface assembly based on π-π interaction. First, Kevlar nanofiber-graphene oxide (K-GO) beads are produced by liquid-liquid phase separation. Then, sodium p-styrenesulfonate (SS) is adsorbed onto the K-GO interface by π-π interaction and initiated to achieve the composite gel (K-GO/PSS) beads with an interfacial crosslinked structure. Such composite gel beads possess superior mechanical strength and self-anticoagulation capability, owing to the dual-network structure and heparin-mimicking gel structure, respectively. Furthermore, the K-GO/PSS beads show robust adsorption capacities for different kinds of toxins due to their strong charge and π-π interactions. A simulated hemoperfusion experiment in vitro demonstrates that the concentrations of the toxins in the blood can be restored to normal values within 30 minutes. In general, we envision that such composite gel beads will provide new strategies for future clinical CLF and CRF treatments.

摘要

最近出现的血液灌流吸附剂,如离子交换树脂、活性炭和其他多孔材料,为治疗慢性肝衰竭 (CLF) 和肾衰竭 (CRF) 提供了许多新的可能性。然而,有限的吸附性能和不理想的血液相容性极大地阻碍了吸附剂的发展。因此,设计安全且具有自抗凝性能、具有强大毒素清除能力的血液灌流吸附剂仍然是一个相当大的挑战。在这里,通过π-π 相互作用的界面组装,制备了全新的基于 Kevlar 的用于血液灌流的复合凝胶珠。首先,通过液-液相分离制备 Kevlar 纳米纤维-氧化石墨烯 (K-GO) 珠。然后,通过π-π 相互作用将对苯乙烯磺酸钠 (SS) 吸附到 K-GO 界面上,并引发实现具有界面交联结构的复合凝胶 (K-GO/PSS) 珠。由于双网络结构和肝素模拟凝胶结构,这种复合凝胶珠具有优异的机械强度和自抗凝能力。此外,由于其强电荷和π-π 相互作用,K-GO/PSS 珠对各种毒素表现出强大的吸附能力。体外模拟血液灌流实验表明,血液中的毒素浓度可在 30 分钟内恢复正常。总的来说,我们预计这种复合凝胶珠将为未来临床 CLF 和 CRF 治疗提供新的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验